Gene to Health Limited

GENE TO HEALTH LIMITED, also known as 基因智健 (G2H), is an Asian company specializing in the application of polygenic score (PGS) technology. They develop multi-omics predictive models for common disease risks and conduct biomedical big data analysis. They provide a smart phenotypic prediction platform with applications in human healthcare (G2H), pet genomics (G2H+Pet), and agricultural breeding (G4B). Their mission is to revolutionize healthcare and other aspects of life through genomics. They are based in Hong Kong and was founded in 2022. They aim to provide comprehensive polygenic score services and combine information from large genomic studies to build precise predictive models for hundreds of phenotypes. The company is led by experts from the statistical genetics lab at HKU Medicine and aims to bridge the gap between scientific advancements and practical applications in various industries. They have received awards and support from HKU and HKSTP.